REG - Hipgnosis Songs Fund - Dividend Declaration

Hipgnosis Songs FundAnnouncement

12/05/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220512:nRSL2405La&default-theme=true

RNS Number : 2405L  Hipgnosis Songs Fund Limited  12 May 2022

LEI: 213800XJIPNDVKXMOC11

12 May 2022

 

HIPGNOSIS SONGS FUND LIMITED

 (the "Company" or "Hipgnosis")

 

Interim Dividend Announcement

 

The Board of Hipgnosis, the first UK listed investment company offering
investors a pure-play exposure to songs and associated musical intellectual
property rights, and its Investment Adviser, Hipgnosis Song Management
Limited, are pleased to announce the Company's interim dividend (the
'Dividend') for the period from 1 January to 31 March 2022 in respect of the
Ordinary shares.

 

The Dividend of 1.3125 pence per Ordinary Share will be payable to
Shareholders on the register as at 20 May 2022 with an associated ex-dividend
date of 19 May 2022 and a payment date of 15 June 2022.

 

 

For further information, please contact:

 Hipgnosis Song Management Limited                                Tel: +44 (0) 20 454 1530; +44 (0)20 452 1511

 Merck Mercuriadis / Rufina Pavry / Giles Croot

 Singer Capital Markets - Joint Corporate Broker                  Tel: +44 (0)20 7496 3000

 James Maxwell / James Moat / Amanda Gray (Corporate Finance)

 Alan Geeves / James Waterlow / Sam Greatrex (Sales)

 J.P. Morgan Cazenove - Joint Corporate Broker                    Tel: +44 (0)20 7742 4000

 William Simmonds / Jérémie Birnbaum (Corporate Finance)

 James Bouverat (Sales)

 RBC Capital Markets - Joint Corporate Broker                     Tel: +44 (0)20 7635 4000

 Elliot Thomas / Max Avison / Lauren Davies (Corporate Finance)

 Lisa Tugwell (Sales)

 Ocorian - Company Secretary & Administrator                      Tel: +44 (0) 28 9693 0222

 Lorna Zimny

 The Outside Organisation                                         Tel: +44 (0)7711 081 843

 Alan Edwards / Nick Caley

 FTI Consulting                                                   Tel: +44 (0)7771 978220; +44 (0)7809 411882; +44 (0)7761 332646

 Neil Doyle/ Paul Harris/ Laura Ewart

 All US music publicity enquiries                                 Tel: +1 917 767 5255

 Fran Defeo

 

 

 

 

NOTES TO EDITORS

About Hipgnosis Songs Fund Limited

(www.hipgnosissongs.com (http://www.hipgnosissongs.com/) )

Hipgnosis, which was founded by Merck Mercuriadis, is a Guernsey registered
investment company established to offer investors a pure-play exposure to
songs and associated musical intellectual property rights. The Company has
raised a total of almost £1.3 billion (gross equity capital) through its
Initial Public Offering on 11 July 2018, and subsequent issues in April 2019,
August 2019, October 2019, July 2020, September 2020, February 2021 and July
2021. In September 2019, Hipgnosis transferred its entire issued share
capital to the Premium listing segment of the Official List of the FCA and to
the London Stock Exchange's Premium segment of the Main Market, and in March
2020 became a constituent of the FTSE 250 Index. Since April 2021, the
Company has been resident in the UK for tax purposes and is recognised as an
investment trust under applicable HMRC regulations.

About Hipgnosis Song Management Limited

 

The Company's Investment Adviser is Hipgnosis Song Management Limited, which
was founded by Merck Mercuriadis, former manager of globally successful
recording artists, such as Elton John, Guns N' Roses, Morrissey, Iron Maiden
and Beyoncé, and hit songwriters such as Diane Warren, Justin Tranter and
The-Dream, and former CEO of The Sanctuary Group plc. The Investment Adviser
has assembled an Advisory Board of highly successful music industry experts
which include award winning members of the artist, songwriter, publishing,
legal, financial, recorded music and music management communities, all with
in-depth knowledge of music publishing. Members of Hipgnosis Song Management
Limited Advisory Board include Nile Rodgers, The-Dream, Giorgio Tuinfort,
Starrah, David A. Stewart, Poo Bear, Bill Leibowitz, Ian Montone and Rodney
Jerkins.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DIVATMATMTTBMRT